Within the clinical trial knowledge with Xyrem in narcolepsy/cataplexy clients at therapeutic doses, two individuals claimed stress and just one claimed insomnia pursuing abrupt discontinuation on the termination on the clinical demo; in the two patients with nervousness, the frequency of cataplexy experienced improved markedly concurrently.Shut No